On November 9th, Merck & Co. Inc. announced that they would pay $4.85 billion to settle product liability claims related to usage of Vioxx.

Lawsuits filed in Birmingham's federal court in recent months claim that popular restaurants, a movie theater chain and a ticket ordering service have violated a law that limits the amount of credit card information companies can print on customers' receipts.

In September of 2004, when Merck voluntarily removed their prescription pain medication, Vioxx, from the market, Product Liability Law once again moved into the realm of everyday news.

Madison County Circuit Judge Daniel Stack may never get to decide whether Frank Schwaller will receive a new trial over his wife's death.

On Nov. 9, Merck & Co., after long insisting it would never settle the 27,000 Vioxx cases filed against it, turned an about face and agreed to a global settlement in which it will pay $4.85 billion to resolve the bulk of these cases.

Plaintiffs in litigation over the painkiller Vioxx are supposed to be able to decide whether to enroll in the übersettlement announced last week or take their cases to court.

A decision by Merck & Co. to pay $4.85 billion to settle thousands of lawsuits over its painkiller Vioxx bought accountability but little comfort for the Palm Coast woman who brought the first federal suit against the company.

A Breakdown on the Vioxx Claims Process

Our firm settled a wrongful death case on October 22nd after a week of trial in an Alabama State Court.

A Montgomery law firm took the charge against pharmaceutical giant Merck & Co., winning a $4.85 billion settlement for thousands nationwide who took the arthritis painkiller Vioxx.